MENU
+Compare
UTMD
Stock ticker: NASDAQ
AS OF
Oct 15, 10:30 AM (EDT)
Price
$60.54
Change
+$0.39 (+0.65%)
Capitalization
192.82M

UTMD Utah Medical Products Forecast, Technical & Fundamental Analysis

Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use... Show more

UTMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for UTMD with price predictions
Oct 14, 2025

Momentum Indicator for UTMD turns negative, indicating new downward trend

UTMD saw its Momentum Indicator move below the 0 level on October 10, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 103 similar instances where the indicator turned negative. In of the 103 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for UTMD turned negative on September 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

UTMD moved below its 50-day moving average on October 13, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UTMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UTMD advanced for three days, in of 248 cases, the price rose further within the following month. The odds of a continued upward trend are .

UTMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 96 cases where UTMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.641) is normal, around the industry mean (10.739). P/E Ratio (16.040) is within average values for comparable stocks, (54.868). UTMD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.742). Dividend Yield (0.020) settles around the average of (0.016) among similar stocks. P/S Ratio (5.195) is also within normal values, averaging (13.726).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UTMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UTMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
UTMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

UTMD paid dividends on October 02, 2025

Utah Medical Products UTMD Stock Dividends
А dividend of $0.31 per share was paid with a record date of October 02, 2025, and an ex-dividend date of September 17, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of specialty medical devices for the healthcare industry

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
7043 South 300 West
Phone
+1 801 566-1200
Employees
216
Web
http://www.utahmed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KLYG0.09N/A
N/A
Kelyniam Global, Inc.
CGROF3.26N/A
N/A
Character Group PLC
LAAOF9.49N/A
N/A
Li Auto Inc.
HGYMF35.51N/A
N/A
Hogy Medical Co. Ltd.
BDVSY25.44-0.28
-1.09%
Bidvest Group Ltd.

UTMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, UTMD has been loosely correlated with CERS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if UTMD jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTMD
1D Price
Change %
UTMD100%
-0.63%
CERS - UTMD
50%
Loosely correlated
+1.28%
TMCI - UTMD
47%
Loosely correlated
+3.33%
INMD - UTMD
47%
Loosely correlated
+0.92%
ITGR - UTMD
44%
Loosely correlated
+1.83%
IART - UTMD
43%
Loosely correlated
+5.73%
More

Groups containing UTMD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTMD
1D Price
Change %
UTMD100%
-0.63%
Pharmaceuticals
category (385 stocks)
38%
Loosely correlated
+0.25%
Pharmaceuticals: Other
category (103 stocks)
34%
Loosely correlated
-0.10%